Valuation: Amgen Inc.

Market Cap 238B 7,757B 203B 190B 174B 327B 22,725B 331B 2,249B 877B 11,416B 892B 872B 37,759B P/E 2026 *
27.8x
P/E 2027 * 24.9x
Enterprise Value 279B 9,111B 239B 224B 205B 384B 26,695B 389B 2,642B 1,030B 13,410B 1,048B 1,025B 44,355B EV / Sales 2026 *
7.17x
EV / Sales 2027 * 6.8x
Free-Float
99.77%
Yield 2026 *
2.3%
Yield 2027 * 2.43%
1 day-3.85%
1 week+0.57%
Current month+8.70%
1 month+13.64%
3 months+28.68%
6 months+19.05%
1 week 3.36
Extreme 3.36
3.66
1 month 3.04
Extreme 3.04
3.66
Current year 2.6
Extreme 2.6
3.66
1 year 2.6
Extreme 2.6
3.66
3 years 2.6
Extreme 2.6
3.66
5 years 2.6
Extreme 2.6
3.66
10 years 2.6
Extreme 2.6
3.66
Manager TitleAgeSince
Chief Executive Officer 63 01/05/2012
Director of Finance/CFO 62 13/05/2010
Director of Finance/CFO 67 01/01/2020
Director TitleAgeSince
Chairman 63 01/01/2013
Director/Board Member 65 01/01/2012
Director/Board Member 71 01/01/2012
Change 5-day change 1-year change 3-year change Capi.($)
-3.85%+0.57% - - 238B
+0.88%+6.38%+76.86%+128.23% 1,119B
+1.07%+3.80%+51.03%+61.48% 651B
+1.20%+6.21%+26.47%+76.45% 468B
+1.02%+5.77%+43.09%+47.70% 374B
+0.85%+4.07%+23.88%+41.58% 302B
+1.26%+6.81%+1.59%+14.67% 259B
+1.88%+5.81%+48.54%+68.52% 238B
+1.59%+2.09%-15.52%-52.29% 208B
+1.87%+5.61%+25.81%+92.42% 181B
Average +0.78%+4.97%+31.31%+53.20% 422.21B
Weighted average by Cap. +0.84%+5.09%+44.31%+72.55%

Financials

2026 *2027 *
Net sales 38.94B 1,272B 33.36B 31.21B 28.57B 53.62B 3,726B 54.32B 369B 144B 1,872B 146B 143B 6,190B 40.2B 1,313B 34.43B 32.22B 29.49B 55.35B 3,846B 56.08B 381B 148B 1,932B 151B 148B 6,390B
Net income 8.6B 281B 7.36B 6.89B 6.31B 11.84B 823B 11.99B 81.41B 31.75B 413B 32.28B 31.58B 1,367B 9.39B 307B 8.05B 7.53B 6.89B 12.93B 899B 13.11B 88.95B 34.69B 451B 35.27B 34.5B 1,493B
Net Debt 41.49B 1,355B 35.54B 33.25B 30.44B 57.12B 3,969B 57.88B 393B 153B 1,994B 156B 152B 6,595B 35.83B 1,170B 30.69B 28.72B 26.29B 49.33B 3,428B 49.98B 339B 132B 1,722B 135B 132B 5,696B
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
21/08/26 THB 3.500 -3.85% 20,009
20/08/26 THB 3.640 +4.00% 21,628
19/08/26 THB 3.500 0.00% 21,902
18/08/26 THB 3.500 +3.55% 4,574
17/08/26 THB 3.380 -2.87% 2,479
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
34
Last Close Price
439.33USD
Average target price
388.48USD
Spread / Average Target
-11.57%

Quarterly revenue - Rate of surprise